Re: Mekinist (Trametinib) a MEK Kinase inhibitor
Paul,
There is a researcher that contacted breast cancer survivors through the Army of Women to test for the KRAS mutation.
I do not believe KRAS is one of the more common mutations of cancer from reading an article that Lani had posted a while back.
Oh COOH, carboxyls. I came across these when I was trying to grasp PCT - which is a deactivation of the uroporphyrinogen decarboxlyase enzyme in the 5th step of Heme production.
I was at the library trying to find material to read to learn more about the basics of these pathways and protein kinases. Nothing I could find locally was helpful.
|